Editors' note: Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study

被引：0
|
作者：
Lewis, Ariane
Galetta, Steven
机构：
来源：
NEUROLOGY | 2019年 / 92卷 / 11期
关键词：
D O I：
10.1212/WNL.0000000000007082
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: the MIRROR study, Bar-Or et al. demonstrated a significant reduction in the number of new brain lesions in patients who were given ofatumumab compared with those who received placebo. However, Dr. Kearney notes that comparing ofatumumab to placebo, rather than a disease-modifying therapy, could have artificially inflated the benefit of ofatumumab.
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [31] Vestibular rehabilitation in patients with relapsing-remitting multiple sclerosis
    Pavan, Karina
    Marangoni, Bruna E. M.
    Schmidt, Kizi B.
    Cobe, Femanda A.
    Matuti, Gabriela S.
    Nishino, Lucia K.
    Thomaz, Rodrigo B.
    Mendes, Maria Fernanda
    Lianza, Sergio
    Tilbery, Charles Peter
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (2A) : 332 - 335
  • [32] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [33] Fingolimod for relapsing-remitting multiple sclerosis
    La Mantia, Loredana
    Tramacere, Irene
    Firwana, Belal
    Pacchetti, Ilaria
    Palumbo, Roberto
    Filippini, Graziella
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [34] Rituximab in relapsing-remitting multiple sclerosis
    Schrijver, Hans M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24): : 2645 - 2645
  • [35] Rituximab for relapsing-remitting multiple sclerosis
    He, Dian
    Zhou, Hongyu
    Han, Wenjie
    Zhang, Shihong
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (12):
  • [36] Natalizumab for relapsing-remitting multiple sclerosis
    Horga, A.
    Tintore, M.
    [J]. NEUROLOGIA, 2011, 26 (06): : 357 - 368
  • [37] Pilot study of minocycline in relapsing-remitting multiple sclerosis
    Zhang, Yunyan
    Metz, Luanne M.
    Yong, V. Wee
    Bell, Robert B.
    Yeung, Michael
    Patry, David G.
    Mitchell, J. Ross
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2008, 35 (02) : 185 - 191
  • [38] Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study
    Filippi, Massimo
    Grimaldi, Luigi
    Conte, Antonella
    Totaro, Rocco
    Valente, Maria Rosaria
    Malucchi, Simona
    Granella, Franco
    Cordioli, Cinzia
    Morra, Vincenzo Brescia
    Zanetta, Chiara
    Perini, Daria
    Santoni, Laura
    EASIER Study Working Grp
    [J]. JOURNAL OF NEUROLOGY, 2024, 271 (01) : 340 - 354
  • [39] Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
    Craner, Matthew
    Al Malik, Yaser
    Babtain, Fawzi A.
    Alshamrani, Foziah
    Alkhawajah, Mona M.
    Alfugham, Nora
    Al-Yafeai, Rumaiza H.
    Aljarallah, Salman
    Makkawi, Seraj
    Qureshi, Shireen
    Ziehn, Marina
    Wahba, Hazem
    [J]. NEUROLOGY AND THERAPY, 2022, 11 (04) : 1457 - 1473
  • [40] Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
    Matthew Craner
    Yaser Al Malik
    Fawzi A. Babtain
    Foziah Alshamrani
    Mona M. Alkhawajah
    Nora Alfugham
    Rumaiza H. Al-Yafeai
    Salman Aljarallah
    Seraj Makkawi
    Shireen Qureshi
    Marina Ziehn
    Hazem Wahba
    [J]. Neurology and Therapy, 2022, 11 : 1457 - 1473
12345